T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Seneca Foods Class A
SENEA
$1.31B
| $304K | ﹤0.01% |
2,745
+310
| +13% | +$35.4K |
|
|
BBBY
2627
Bed Bath & Beyond
BBBY
$423M
| $302K | ﹤0.01% |
55,180
-1,722
| -3% | -$12.5K |
|
2628
Corsair Gaming
CRSR
$1.45B
| $301K | ﹤0.01% |
50,573
+4,840
| +11% | +$33.7K |
|
2629
Great Southern Bancorp
GSBC
$888M
| $299K | ﹤0.01% |
4,857
+318
| +7% | +$19.1K |
|
2630
RPC Inc
RES
$1.39B
| $299K | ﹤0.01% |
54,895
+7,808
| +17% | +$40.6K |
|
2631
Transcat
TRNS
$888M
| $299K | ﹤0.01% |
5,265
+432
| +9% | +$26.9K |
|
2632
Preformed Line Products
PLPC
$2.19B
| $298K | ﹤0.01% |
1,437
+160
| +13% | +$34.1K |
|
2633
Rimini Street
RMNI
$470M
| $298K | ﹤0.01% |
76,741
| – | – |
|
2634
South Plains Financial
SPFI
$859M
| $298K | ﹤0.01% |
7,667
+844
| +12% | +$32.3K |
|
2635
Xerox
XRX
$412M
| $297K | ﹤0.01% |
125,066
+16,379
| +15% | +$48.5K |
|
2636
Mission Produce
AVO
$1.15B
| $296K | ﹤0.01% |
25,502
+3,013
| +13% | +$36.1K |
|
2637
Dakota Gold
DC
$827M
| $296K | ﹤0.01% |
51,986
+6,083
| +13% | +$29.2K |
|
2638
iShares Russell 3000 ETF
IWV
$20.6B
| $296K | ﹤0.01% |
764
| – | – |
|
2639
CEVA Inc
CEVA
$855M
| $295K | ﹤0.01% |
13,680
+1,270
| +10% | +$31.2K |
|
2640
America's Car Mart
CRMT
$25.7M
| $295K | ﹤0.01% |
+11,674
| New | +$281K |
|
|
ACRE
2641
Ares Commercial Real Estate
ACRE
$264M
| $294K | ﹤0.01% |
61,412
-23,590
| -28% | -$115K |
|
2642
Redwire
RDW
$3.3B
| $294K | ﹤0.01% |
38,681
+12,143
| +46% | +$89.1K |
|
2643
Third Coast Bancshares
TCBX
$766M
| $292K | ﹤0.01% |
7,674
+838
| +12% | +$32.1K |
|
2644
U-Haul Holding Co
UHAL
$14.4B
| $292K | ﹤0.01% |
5,786
-1,485
| -20% | -$79K |
|
|
CCRN
2645
DELISTED
Cross Country Healthcare
CCRN
| $291K | ﹤0.01% |
35,838
+8,748
| +32% | +$95.6K |
|
2646
4D Molecular Therapeutics
FDMT
$609M
| $291K | ﹤0.01% |
38,747
-6,281
| -14% | -$63.7K |
|
2647
Farmers National Banc Corp
FMNB
$970M
| $291K | ﹤0.01% |
21,773
+2,431
| +13% | +$33.3K |
|
2648
Oil-Dri
ODC
$1.27B
| $290K | ﹤0.01% |
5,912
+667
| +13% | +$37K |
|
2649
Rush Enterprises Class B
RUSHB
$9.37B
| $289K | ﹤0.01% |
5,125
+538
| +12% | +$29.4K |
|
2650
Zevra Therapeutics
ZVRA
$664M
| $288K | ﹤0.01% |
32,140
+3,648
| +13% | +$34.5K |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.